Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 07.01.2025
Schaeffler AG
Schaeffler at CES 2025 Schaeffler Unveils New Era of Motion Technology at CES 2025
Merger with Vitesco Technologies expands expertise, product portfolio and footprint
Schaeffler to unveil robust motion product portfolio at CES 2025
Experience the Humanoid Technology Exhibit, Dynamic Performance Vehicle, and The Motion Hub at CES 2025
Herz [ … ]
Tue, 07.01.2025
Ideal Property Mallorca
Why Majorca Is the Ultimate Destination for 2025 Trends, According to Ideal Property Mallorca
As travel evolves, new trends are reshaping the way we explore the world. Ideal Property Mallorca explains why Majorca provides the perfect setting to embrace the 2025 trends.
Mallorca, Spain
As travel evolves, new trends are shaping how we explore the [ … ]
Tue, 07.01.2025
Rubean AG
Rubean AG has almost doubled its annual revenue to EUR 1.94 million in 2024
Annual turnover of the FinTech company increases by over 90 per cent compared to the previous year according to initial figures
Capital increase with subscription rights completed
Talks with strategic partner
Munich, 7 January 2025. The fintech company Rubean AG, Munich [ … ]
Tue, 07.01.2025
QUANTRO Therapeutics GmbH
Press Release
QUANTRO Therapeutics achieves breakthrough in transcriptomic drug discovery with first successful simultaneous 10-target multiplex-screening
QUANTRO’s proprietary time-resolved functional transcriptomic discovery platform accelerates target screening for complex indications in oncology and inflammation
QUANTRO CEO Dr. Michael Bauer [ … ]
Tue, 07.01.2025
Immunic AG
Immunic Highlights 2024 Accomplishments and Upcoming Milestones
– Top-Line Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis Expected in April –
– Reported Positive Outcome from Interim Analysis of Ongoing, Twin Phase 3 ENSURE Trials of Vidofludimus Calcium in Relapsing Multiple Sclerosis; Both Trials on [ … ]
Tue, 07.01.2025
Best Places to Work
EQS Newswire / 07/01/2025 / 11:29 CET/CEST
LONDON, UNITED KINGDOM - Media OutReach Newswire - 7 January 2025 - The Best Places to Work organization is proud to announce the Top 25 Best Places to Work in Europe for 2024, recognizing the most outstanding employers who have demonstrated exceptional commitment to fostering positive, inclusive, and [ … ]
Tue, 07.01.2025
INDUS Holding AG
INDUS purchases company for the future field of infrastructure networks
INDUS subsidiary HAUFF-TECHNIK buys KETTLER
Specialist for spindle extensions for pipe systems
Complementary addition strengthens the infrastructure segment
Bergisch Gladbach, 7 January 2025 – HAUFF-TECHNIK GmbH & Co. KG, a subsidiary of listed INDUS Holding AG, acquir [ … ]
Tue, 07.01.2025
Pentixapharm Holding AG
Berlin, January 7th, 2025 – Pentixapharm AG, a developer of innovative radiopharmaceuticals, receives 6.77 million Euro for intangible assets formerly developed by Glycotope from undisclosed Asian pharma and biotech companies. The transaction, which will be effective still in 2024, involves rights that had been transferred to Pentixapharm as part o [ … ]
Tue, 07.01.2025
Alzchem Group AG
Disclosure according to Article 5 of the EU Regulation 596/2014 and
Article 2 Section (1) of the Delegated EU Regulation 2016/1052
Trostberg, January 7th, 2025
4th Interim Report
In the period from December 30th, 2024, up to and including January 3rd, 2025, a total of 5,077 shares of Alzchem Group AG were acquired as part of the [ … ]
Tue, 07.01.2025
PNE AG
Corporate News
Dirk Simons is the new Chairman of the Supervisory Board of PNE AG
Assumption of the position on 1 January 2025
Dirk Simons takes over from Marc van't Noordende
Cuxhaven, January 7, 2025 – At the beginning of the year, Dirk Simons took over as Chairman of the Supervisory Board of PNE AG from Marc van't Noordende, who had been Ch [ … ]